Kapitel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
Index
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Kapitel in diesem Buch
- Frontmatter I
- Preface V
- Contents VII
- List of authors IX
- 1 Contemporary trends in drug repurposing: Identifying new targets for existing drugs 1
- 2 Intellectual property and regulatory considerations in drug repurposing 23
- 3 Drug repurposing from an academic and industrial view 41
- 4 Implication of drug repurposing in the identification of drugs for neurological disorders 55
- 5 Implication of drug repurposing in the identification of drugs as antiviral agents 101
- 6 Implication of drug repurposing in the identification of antibacterial agents 115
- 7 The implication of drug repurposing in the identification of drugs for gastrointestinal disorders 139
- 8 Implication of drug repurposing in the identification of drugs for renal disorders 159
- 9 Drug repurposing strategy in the identification of drugs for cardiovascular disorders 181
- 10 Successful examples of blockbusters drugs for drug repurposing 207
- 11 Drug repurposing of drugs from natural and marine origins 221
- 12 Drug repurposing of selective COX-2 inhibitors in the pursuit of new therapeutic avenues 233
- 13 Advantages, opportunities, and challenges to drug repurposing 283
- Index 293
Kapitel in diesem Buch
- Frontmatter I
- Preface V
- Contents VII
- List of authors IX
- 1 Contemporary trends in drug repurposing: Identifying new targets for existing drugs 1
- 2 Intellectual property and regulatory considerations in drug repurposing 23
- 3 Drug repurposing from an academic and industrial view 41
- 4 Implication of drug repurposing in the identification of drugs for neurological disorders 55
- 5 Implication of drug repurposing in the identification of drugs as antiviral agents 101
- 6 Implication of drug repurposing in the identification of antibacterial agents 115
- 7 The implication of drug repurposing in the identification of drugs for gastrointestinal disorders 139
- 8 Implication of drug repurposing in the identification of drugs for renal disorders 159
- 9 Drug repurposing strategy in the identification of drugs for cardiovascular disorders 181
- 10 Successful examples of blockbusters drugs for drug repurposing 207
- 11 Drug repurposing of drugs from natural and marine origins 221
- 12 Drug repurposing of selective COX-2 inhibitors in the pursuit of new therapeutic avenues 233
- 13 Advantages, opportunities, and challenges to drug repurposing 283
- Index 293